TipRanks
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market

OncoArendi Therapeutics SA (MOC) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
OncoArendi Therapeutics SA’s (MOC) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting OncoArendi Therapeutics SA is a Buy.
OncoArendi Therapeutics SA’s (MOC) 20-Day exponential moving average is 6.43, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.95, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) 50-Day exponential moving average is 6.53, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.95, making it a Sell.

OncoArendi Therapeutics SA (MOC) Pivot Points

Oct 25, 2026, 11:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.58
5.70
5.84
5.96
6.10
6.22
6.36
Fibonacci
5.70
5.80
5.86
5.96
6.06
6.12
6.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (MOC) Moving Averages

Oct 25, 2026, 11:39 PM
Period
Simple
Exponential
MA5
5.98Sell
5.97Sell
MA10
6.21Sell
6.18Sell
MA20
6.52Sell
6.43Sell
MA50
6.66Sell
6.53Sell
MA100
6.25Sell
6.39Sell
MA200
6.26Sell
6.43Sell
OncoArendi Therapeutics SA’s (MOC) 10-Day exponential moving average is 6.18, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.95, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) 100-Day exponential moving average is 6.39, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.95, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.95 and OncoArendi Therapeutics SA’s (MOC) 50-day simple moving average is 6.66, creating a Sell signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.95 and OncoArendi Therapeutics SA’s (MOC) 100-day simple moving average is 6.25, creating a Sell signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.95 and OncoArendi Therapeutics SA’s (MOC) 200-day simple moving average is 6.26, creating a Sell signal.

OncoArendi Therapeutics SA (MOC) Technical Indicators

Oct 25, 2026, 11:39 PM
Name
Value
Implied Action
RSI (14)
28.62
Buy
STOCH (9,6)
15.81
Buy
STOCHRSI (14)
11.02
Buy
MACD (12,26)
-0.26
Buy
ADX (14)
23.36
Neutral
Williams %R
-88.55
Buy
CCI (14)
-172.61
Buy
ATR (14)
0.41
-
Ultimate Oscillator
36.44
Neutral
ROC
-19.86
Sell
OncoArendi Therapeutics SA’s (MOC) Relative Strength Index (RSI) is 28.62, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) Trend Strength Indicator (ADX) is 23.36, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Commodity Channel Index (CCI) is -172.61, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) Price Rate of Change (ROC) is -19.86, creating a Sell signal.

FAQ

Is MOC a Buy, Hold, or Sell?
Based on MOC’s technical indicators, MOC is a Sell.
    What is MOC’s RSI (14)?
    MOC’s RSI (14) is 28.62, which suggests MOC is a Buy.
      What is MOC’s MACD?
      MOC’s MACD is -0.26, which suggests MOC is a Buy.
        What is MOC’s 5-day moving average?
        MOC’s 5-day moving average is 5.98, which suggests MOC is a Sell.
          What is MOC’s 20-day moving average?
          MOC 20-day moving average is 6.52, which suggests MOC is a Sell.
            What is MOC’s 50-day moving average?
            MOC’s 50-day moving average is 6.66, which suggests MOC is a Sell.
              What is MOC’s 200-day moving average?
              MOC’s 200-day moving average is 6.26, which suggests MOC is a Sell.
                What is MOC’s Williams % R (14)?
                MOC’s Williams % R (14) is -88.55, which suggests MOC is a Buy.
                  What is MOC’s CCI (14)?
                  MOC’s CCI (14) is -172.61, which suggests MOC is a Buy.
                    What is the share price of OncoArendi Therapeutics SA?